These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2310998)
1. Assessment of ischemic injury and protective interventions: the Langendorff versus the working rat heart preparation. Galinanes M; Hearse DJ Can J Cardiol; 1990 Mar; 6(2):83-91. PubMed ID: 2310998 [TBL] [Abstract][Full Text] [Related]
2. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution. Yang SS; Hearse DJ Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036 [TBL] [Abstract][Full Text] [Related]
3. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. Kempsford RD; Hearse DJ J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart. Greenfield DT; Greenfield LJ; Hess ML J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928 [TBL] [Abstract][Full Text] [Related]
5. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection. GaliƱanes M; Hearse DJ Cardioscience; 1990 Jun; 1(2):127-43. PubMed ID: 2102801 [TBL] [Abstract][Full Text] [Related]
6. Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long-term hypothermic storage and transplantation. GaliƱanes M; Hearse DJ J Thorac Cardiovasc Surg; 1992 Jul; 104(1):151-8. PubMed ID: 1614201 [TBL] [Abstract][Full Text] [Related]
7. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. Bessho R; Chambers DJ J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806 [TBL] [Abstract][Full Text] [Related]
8. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium. Baker JE; Boerboom LE; Olinger GN J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966 [TBL] [Abstract][Full Text] [Related]
9. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion. Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts. Qiu Y; Hearse DJ J Thorac Cardiovasc Surg; 1992 May; 103(5):960-8. PubMed ID: 1569777 [TBL] [Abstract][Full Text] [Related]
11. Protection of the chronic hypoxic immature rat heart during global ischemia. Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715 [TBL] [Abstract][Full Text] [Related]
12. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution. Kinoshita K; Oe M; Tokunaga K J Thorac Cardiovasc Surg; 1991 Apr; 101(4):695-702. PubMed ID: 2008108 [TBL] [Abstract][Full Text] [Related]
13. Perfusate calcium: effect on cardiac stability and response to ischemia and reperfusion. Chambers DJ; Braimbridge MV; Hearse DJ Can J Cardiol; 1991 Nov; 7(9):410-8. PubMed ID: 1756421 [TBL] [Abstract][Full Text] [Related]
14. [The experimental study of myocardial protection for warm myocardial ischemia in an isolated rat heart: the effect of a calcium antagonist]. Fukuhiro Y Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):130-7. PubMed ID: 8717259 [TBL] [Abstract][Full Text] [Related]
15. Effect of combining phosphodiesterase III inhibitors with St Thomas Hospital's solution used as transplantation preservative solution in isolated rat hearts. Besirli K; Burhani SM; Arslan C; Suzer O; Sayin AG Transplant Proc; 2006 Jun; 38(5):1253-8. PubMed ID: 16797275 [TBL] [Abstract][Full Text] [Related]
16. [The effects of protease inhibitor upon the ischemia-reperfusion injury]. Shibata T; Yamamoto F; Ohashi T; Shimada Y; Nakajima N; Kinoshita H; Kawashima Y Nihon Kyobu Geka Gakkai Zasshi; 1992 Oct; 40(10):1853-8. PubMed ID: 1431402 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts. Akita T; Abe T; Kato S; Kodama I; Toyama J J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005 [TBL] [Abstract][Full Text] [Related]
18. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat. Ledingham SJ; Braimbridge MV; Hearse DJ J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223 [TBL] [Abstract][Full Text] [Related]
19. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits]. Zhou RH; Long C; Liu J; Liu B Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293 [TBL] [Abstract][Full Text] [Related]
20. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution. Maruyama Y; Chambers DJ Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]